Filtros : "Indexado no EMBASE" "Emirados Árabes Unidos" Removido: "BIOENERGIA" Limpar

Filtros



Refine with date range


  • Source: Current Neuropharmacology. Unidades: FMRP, FCFRP, IRI

    Subjects: CANABINOIDES, INFLAMAÇÃO, TECIDO NERVOSO, DEGENERAÇÃO NEURAL, DOENÇAS DO SISTEMA NERVOSO, TRANSTORNOS PSICÓTICOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      HARTMANN, Alice et al. The NLRP3 inflammasome in stress response: another target for the promiscuous cannabidiol. Current Neuropharmacology, v. 21, n. 2, p. 284-308, 2023Tradução . . Disponível em: https://doi.org/10.2174/1570159X20666220411101217. Acesso em: 12 jun. 2024.
    • APA

      Hartmann, A., Vila-Verde, C., Guimarães, F. S., Wegener, S. R. L. J., & Lisboa, S. F. de S. (2023). The NLRP3 inflammasome in stress response: another target for the promiscuous cannabidiol. Current Neuropharmacology, 21( 2), 284-308. doi:10.2174/1570159X20666220411101217
    • NLM

      Hartmann A, Vila-Verde C, Guimarães FS, Wegener SRLJ, Lisboa SF de S. The NLRP3 inflammasome in stress response: another target for the promiscuous cannabidiol [Internet]. Current Neuropharmacology. 2023 ; 21( 2): 284-308.[citado 2024 jun. 12 ] Available from: https://doi.org/10.2174/1570159X20666220411101217
    • Vancouver

      Hartmann A, Vila-Verde C, Guimarães FS, Wegener SRLJ, Lisboa SF de S. The NLRP3 inflammasome in stress response: another target for the promiscuous cannabidiol [Internet]. Current Neuropharmacology. 2023 ; 21( 2): 284-308.[citado 2024 jun. 12 ] Available from: https://doi.org/10.2174/1570159X20666220411101217
  • Source: Current Hypertension Reviews. Unidade: EERP

    Subjects: ANTIOXIDANTES, PRESSÃO SANGUÍNEA, HIPERTENSÃO, ESTRESSE OXIDATIVO, ESPÉCIES REATIVAS DE OXIGÊNIO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PINHEIRO, Lucas Cezar e OLIVEIRA-PAULA, Gustavo H. Sources and effects of oxidative stress in hypertension. Current Hypertension Reviews, v. 16, n. 3, p. 166-180, 2021Tradução . . Disponível em: https://doi.org/10.2174/1573402115666190531071924. Acesso em: 12 jun. 2024.
    • APA

      Pinheiro, L. C., & Oliveira-Paula, G. H. (2021). Sources and effects of oxidative stress in hypertension. Current Hypertension Reviews, 16( 3), 166-180. doi:10.2174/1573402115666190531071924
    • NLM

      Pinheiro LC, Oliveira-Paula GH. Sources and effects of oxidative stress in hypertension [Internet]. Current Hypertension Reviews. 2021 ; 16( 3): 166-180.[citado 2024 jun. 12 ] Available from: https://doi.org/10.2174/1573402115666190531071924
    • Vancouver

      Pinheiro LC, Oliveira-Paula GH. Sources and effects of oxidative stress in hypertension [Internet]. Current Hypertension Reviews. 2021 ; 16( 3): 166-180.[citado 2024 jun. 12 ] Available from: https://doi.org/10.2174/1573402115666190531071924
  • Source: Letters in Drug Design & Discovery. Unidade: FCFRP

    Subjects: TRYPANOSOMA CRUZI, TRIPANOSSOMICIDAS, ENSAIO CLÍNICO, CITOTOXICIDADE IMUNOLÓGICA, ANTIPARASITÁRIOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LIMA, Camilo Henrique da Silva et al. Anti-Trypanosoma cruzi activity and molecular docking studies of 1Hpyrazolo[ 3, 4-b]pyridine derivatives. Letters in Drug Design & Discovery, v. 17, n. 2, p. 184-191, 2020Tradução . . Disponível em: https://doi.org/10.2174/1570180816666190305141733. Acesso em: 12 jun. 2024.
    • APA

      Lima, C. H. da S., Soares, J. C. de A. V., Ribeiro, J. L. de S., Muri, E. M. F., Albuquerque, S. de, & Dias, L. R. S. (2020). Anti-Trypanosoma cruzi activity and molecular docking studies of 1Hpyrazolo[ 3, 4-b]pyridine derivatives. Letters in Drug Design & Discovery, 17( 2), 184-191. doi:10.2174/1570180816666190305141733
    • NLM

      Lima CH da S, Soares JC de AV, Ribeiro JL de S, Muri EMF, Albuquerque S de, Dias LRS. Anti-Trypanosoma cruzi activity and molecular docking studies of 1Hpyrazolo[ 3, 4-b]pyridine derivatives [Internet]. Letters in Drug Design & Discovery. 2020 ; 17( 2): 184-191.[citado 2024 jun. 12 ] Available from: https://doi.org/10.2174/1570180816666190305141733
    • Vancouver

      Lima CH da S, Soares JC de AV, Ribeiro JL de S, Muri EMF, Albuquerque S de, Dias LRS. Anti-Trypanosoma cruzi activity and molecular docking studies of 1Hpyrazolo[ 3, 4-b]pyridine derivatives [Internet]. Letters in Drug Design & Discovery. 2020 ; 17( 2): 184-191.[citado 2024 jun. 12 ] Available from: https://doi.org/10.2174/1570180816666190305141733
  • Source: Current Pharmaceutical Design. Unidades: FCFRP, ICB

    Subjects: CÉLULAS ENDOTELIAIS, ENDOTÉLIO VASCULAR, ÓXIDO NÍTRICO, FARMACOLOGIA, DOENÇAS VASCULARES

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PAULO, Michele et al. Nitric oxide donors as ootential drugs for the treatment of vascular diseases due to endothelium dysfunction. Current Pharmaceutical Design, v. 26, n. 30, p. 3748-3759, 2020Tradução . . Disponível em: https://doi.org/10.2174/1381612826666200519114442. Acesso em: 12 jun. 2024.
    • APA

      Paulo, M., Costa, D. E. F. R., Bonaventura, D., Lunardi, C. N., & Bendhack, L. M. (2020). Nitric oxide donors as ootential drugs for the treatment of vascular diseases due to endothelium dysfunction. Current Pharmaceutical Design, 26( 30), 3748-3759. doi:10.2174/1381612826666200519114442
    • NLM

      Paulo M, Costa DEFR, Bonaventura D, Lunardi CN, Bendhack LM. Nitric oxide donors as ootential drugs for the treatment of vascular diseases due to endothelium dysfunction [Internet]. Current Pharmaceutical Design. 2020 ; 26( 30): 3748-3759.[citado 2024 jun. 12 ] Available from: https://doi.org/10.2174/1381612826666200519114442
    • Vancouver

      Paulo M, Costa DEFR, Bonaventura D, Lunardi CN, Bendhack LM. Nitric oxide donors as ootential drugs for the treatment of vascular diseases due to endothelium dysfunction [Internet]. Current Pharmaceutical Design. 2020 ; 26( 30): 3748-3759.[citado 2024 jun. 12 ] Available from: https://doi.org/10.2174/1381612826666200519114442
  • Source: Current Neuropharmacology. Unidade: FMRP

    Subjects: ALUCINOGÊNICOS, NEUROFARMACOLOGIA, TRANSTORNOS MENTAIS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      HAMILL, Jonathan et al. Ayahuasca: psychological and physiologic effects, pharmacology and potential uses in addiction and mental illness. Current Neuropharmacology, v. 17, n. 2, p. 108-128, 2019Tradução . . Disponível em: https://doi.org/10.2174/1570159x16666180125095902. Acesso em: 12 jun. 2024.
    • APA

      Hamill, J., Hallak, J. E. C., Dursun, S. M., & Baker, G. (2019). Ayahuasca: psychological and physiologic effects, pharmacology and potential uses in addiction and mental illness. Current Neuropharmacology, 17( 2), 108-128. doi:10.2174/1570159x16666180125095902
    • NLM

      Hamill J, Hallak JEC, Dursun SM, Baker G. Ayahuasca: psychological and physiologic effects, pharmacology and potential uses in addiction and mental illness [Internet]. Current Neuropharmacology. 2019 ; 17( 2): 108-128.[citado 2024 jun. 12 ] Available from: https://doi.org/10.2174/1570159x16666180125095902
    • Vancouver

      Hamill J, Hallak JEC, Dursun SM, Baker G. Ayahuasca: psychological and physiologic effects, pharmacology and potential uses in addiction and mental illness [Internet]. Current Neuropharmacology. 2019 ; 17( 2): 108-128.[citado 2024 jun. 12 ] Available from: https://doi.org/10.2174/1570159x16666180125095902
  • Source: Current Drug Targets. Unidade: FMRP

    Subjects: HIPERTENSÃO, ÓXIDO NÍTRICO, NITRATOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      OLIVEIRA-PAULA, Gustavo H. e TANUS-SANTOS, José Eduardo. Nitrite-stimulated gastric formation of S-nitrosothiols as an antihypertensive therapeutic strategy. Current Drug Targets, v. 20, n. 4, p. 431-443, 2019Tradução . . Disponível em: https://doi.org/10.2174/1389450119666180816120816. Acesso em: 12 jun. 2024.
    • APA

      Oliveira-Paula, G. H., & Tanus-Santos, J. E. (2019). Nitrite-stimulated gastric formation of S-nitrosothiols as an antihypertensive therapeutic strategy. Current Drug Targets, 20( 4), 431-443. doi:10.2174/1389450119666180816120816
    • NLM

      Oliveira-Paula GH, Tanus-Santos JE. Nitrite-stimulated gastric formation of S-nitrosothiols as an antihypertensive therapeutic strategy [Internet]. Current Drug Targets. 2019 ; 20( 4): 431-443.[citado 2024 jun. 12 ] Available from: https://doi.org/10.2174/1389450119666180816120816
    • Vancouver

      Oliveira-Paula GH, Tanus-Santos JE. Nitrite-stimulated gastric formation of S-nitrosothiols as an antihypertensive therapeutic strategy [Internet]. Current Drug Targets. 2019 ; 20( 4): 431-443.[citado 2024 jun. 12 ] Available from: https://doi.org/10.2174/1389450119666180816120816
  • Source: Current Topics in Medicinal Chemistry. Unidade: FCFRP

    Subjects: TRIPANOSSOMICIDAS, DOENÇAS DE CHAGAS, GLICOCONJUGADOS, TRYPANOSOMA CRUZI, VACINAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CAMPO, Vanessa Leiria e MARCHIORI, Marcelo Fiori e CARVALHO, Ivone. Insights into anti-trypanosomal agents based on synthetic glycoconjugates. Current Topics in Medicinal Chemistry, v. 18, n. 5, p. 382-396, 2018Tradução . . Disponível em: https://doi.org/10.2174/1568026618666180509145305. Acesso em: 12 jun. 2024.
    • APA

      Campo, V. L., Marchiori, M. F., & Carvalho, I. (2018). Insights into anti-trypanosomal agents based on synthetic glycoconjugates. Current Topics in Medicinal Chemistry, 18( 5), 382-396. doi:10.2174/1568026618666180509145305
    • NLM

      Campo VL, Marchiori MF, Carvalho I. Insights into anti-trypanosomal agents based on synthetic glycoconjugates [Internet]. Current Topics in Medicinal Chemistry. 2018 ; 18( 5): 382-396.[citado 2024 jun. 12 ] Available from: https://doi.org/10.2174/1568026618666180509145305
    • Vancouver

      Campo VL, Marchiori MF, Carvalho I. Insights into anti-trypanosomal agents based on synthetic glycoconjugates [Internet]. Current Topics in Medicinal Chemistry. 2018 ; 18( 5): 382-396.[citado 2024 jun. 12 ] Available from: https://doi.org/10.2174/1568026618666180509145305
  • Source: Current Vascular Pharmacology. Unidade: FMRP

    Subjects: HIPERTENSÃO, RATOS, ÓXIDO NÍTRICO, ANGIOTENSINA II

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      WYNNE, Brandi M. et al. Nitroxyl anion mediates relaxation in mesenteric arteries from angiotensin II hypertensive mice. Current Vascular Pharmacology, v. 16, n. 1, p. 93-101, 2018Tradução . . Disponível em: https://doi.org/10.2174/1570161115666170725151509. Acesso em: 12 jun. 2024.
    • APA

      Wynne, B. M., Labazi, H., Passaglia, R. de C. A. T., & Webb, R. C. (2018). Nitroxyl anion mediates relaxation in mesenteric arteries from angiotensin II hypertensive mice. Current Vascular Pharmacology, 16( 1), 93-101. doi:10.2174/1570161115666170725151509
    • NLM

      Wynne BM, Labazi H, Passaglia R de CAT, Webb RC. Nitroxyl anion mediates relaxation in mesenteric arteries from angiotensin II hypertensive mice [Internet]. Current Vascular Pharmacology. 2018 ; 16( 1): 93-101.[citado 2024 jun. 12 ] Available from: https://doi.org/10.2174/1570161115666170725151509
    • Vancouver

      Wynne BM, Labazi H, Passaglia R de CAT, Webb RC. Nitroxyl anion mediates relaxation in mesenteric arteries from angiotensin II hypertensive mice [Internet]. Current Vascular Pharmacology. 2018 ; 16( 1): 93-101.[citado 2024 jun. 12 ] Available from: https://doi.org/10.2174/1570161115666170725151509
  • Source: Current Pharmaceutical Analysis. Unidade: FCF

    Subjects: DROGAS DE ABUSO, ANÁLISE TOXICOLÓGICA

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      OLIVEIRA, Carolina Dizioli Rodrigues de et al. Recent advances in chromatographic methods to detect drugs of abuse in alternative biological matrices. Current Pharmaceutical Analysis, v. 3, n. 2, p. 95-109, 2007Tradução . . Acesso em: 12 jun. 2024.
    • APA

      Oliveira, C. D. R. de, Rohesig, M., Almeida, R. M. de, Rocha, W. L., & Yonamine, M. (2007). Recent advances in chromatographic methods to detect drugs of abuse in alternative biological matrices. Current Pharmaceutical Analysis, 3( 2), 95-109.
    • NLM

      Oliveira CDR de, Rohesig M, Almeida RM de, Rocha WL, Yonamine M. Recent advances in chromatographic methods to detect drugs of abuse in alternative biological matrices. Current Pharmaceutical Analysis. 2007 ; 3( 2): 95-109.[citado 2024 jun. 12 ]
    • Vancouver

      Oliveira CDR de, Rohesig M, Almeida RM de, Rocha WL, Yonamine M. Recent advances in chromatographic methods to detect drugs of abuse in alternative biological matrices. Current Pharmaceutical Analysis. 2007 ; 3( 2): 95-109.[citado 2024 jun. 12 ]
  • Source: Recent Patents on CNS Drug Discovery. Unidade: IQ

    Assunto: DOENÇAS NEURODEGENERATIVAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      RESENDE, Rodrigo Ribeiro e ULRICH, Henning e FARIA, Marcella. Is there a Rational Approach for Increasing Drug Specificity? Considerations on CNS Target Choice and Validation. Recent Patents on CNS Drug Discovery, v. 2, n. 1, p. 37-46, 2007Tradução . . Disponível em: https://doi.org/10.2174/157488907779561736. Acesso em: 12 jun. 2024.
    • APA

      Resende, R. R., Ulrich, H., & Faria, M. (2007). Is there a Rational Approach for Increasing Drug Specificity? Considerations on CNS Target Choice and Validation. Recent Patents on CNS Drug Discovery, 2( 1), 37-46. doi:10.2174/157488907779561736
    • NLM

      Resende RR, Ulrich H, Faria M. Is there a Rational Approach for Increasing Drug Specificity? Considerations on CNS Target Choice and Validation [Internet]. Recent Patents on CNS Drug Discovery. 2007 ;2( 1): 37-46.[citado 2024 jun. 12 ] Available from: https://doi.org/10.2174/157488907779561736
    • Vancouver

      Resende RR, Ulrich H, Faria M. Is there a Rational Approach for Increasing Drug Specificity? Considerations on CNS Target Choice and Validation [Internet]. Recent Patents on CNS Drug Discovery. 2007 ;2( 1): 37-46.[citado 2024 jun. 12 ] Available from: https://doi.org/10.2174/157488907779561736
  • Source: Anti-Infective Agents in Medicinal Chemistry. Unidade: IQ

    Subjects: SURFACTANTES, BIOQUÍMICA

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CARMONA-RIBEIRO, Ana Maria e VIEIRA, Débora Braga e LINCOPAN, Nilton. Cationic surfactants and lipids as anti-infective agents. Anti-Infective Agents in Medicinal Chemistry, v. 5, n. 1, p. 33-54, 2006Tradução . . Acesso em: 12 jun. 2024.
    • APA

      Carmona-Ribeiro, A. M., Vieira, D. B., & Lincopan, N. (2006). Cationic surfactants and lipids as anti-infective agents. Anti-Infective Agents in Medicinal Chemistry, 5( 1), 33-54.
    • NLM

      Carmona-Ribeiro AM, Vieira DB, Lincopan N. Cationic surfactants and lipids as anti-infective agents. Anti-Infective Agents in Medicinal Chemistry. 2006 ; 5( 1): 33-54.[citado 2024 jun. 12 ]
    • Vancouver

      Carmona-Ribeiro AM, Vieira DB, Lincopan N. Cationic surfactants and lipids as anti-infective agents. Anti-Infective Agents in Medicinal Chemistry. 2006 ; 5( 1): 33-54.[citado 2024 jun. 12 ]

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024